- Filed patents to protect company’s process and products
- Powderized cannabis products deliver precise CBD/THC dosing with superior cannabinoid solubility
- Signed strategic partnership and licensing agreement with Avitas CBD Water
After thousands of years of human use, cannabis is now at the center of a new revolution. The medical efficacy of certain cannabinoids is now settled science, and numerous advanced therapeutic applications are currently in development. Recreational cannabis use has gained broad acceptance in multiple U.S. states and, in a few months, becomes legal across all of Canada. However, whether for medicinal or recreational purposes, there have been long-standing problems with dosing precision and effective bioavailability related to cannabis usage.
Xanthic Biopharma Inc. is changing the landscape and establishing a new paradigm in precise and effective cannabinoid delivery. The company recently filed a patent application to protect its proprietary processes to powderize the active ingredients in cannabis, including both THC and CBD (http://cnw.fm/n97YL). Since it’s a fat, cannabis doesn’t readily mix with water. Xanthic’s innovative process makes cannabinoids water-soluble, allowing for precise dosing while significantly increasing the bioavailability of active ingredients. The company’s patent application also seeks to protect powdered cannabis products made according to proprietary processes.
In a news release, Tim Moore, CEO of Xanthic, commented, “Xanthic is extremely excited to have developed this industry-leading technology. The company’s technology provides a competitive advantage in the marketplace and we have taken the logical step of seeking patent protection for the company’s proprietary processes and products. Our break through process allows for full spectrum cannabinoid water solubility with maximum bioavailability. This is an industry first and will add a great deal of value for our strategic partners.”
Simple, easy and convenient to use, all it takes is a bottle of water added to any of Xanthic’s powderized products to consume cannabis. This novel technology has applications across a broad range of powdered and infused medical and recreational cannabis products, and Xanthic is wasting no time in establishing it as the industry standard.
Employing a unique business model, Xanthic is licensing with approved cannabis producers, allowing them to sell new precise dosage products at higher price points. With a low capital investment and a small footprint in their facilities, licensed producers can achieve greater revenues by converting their existing products to higher value products that capitalize on the multiple benefits of precise dosing, convenience and increased bioavailability.
Xanthic recently announced that it has entered into a licensing and strategic partnership agreement with Avitas CBD Water, LLC (http://cnw.fm/0lZFY). Based in Portland, Oregon, Avitas will be producing and distributing CBD-infused water, co-branded with ‘Powered by Xanthic Solubles’.
“This strategic partnership is Xanthic’s first step in proving that our proprietary technology is a viable licensing investment for producers and distributors across North America. We’re thrilled to be able to not only license our brand to Avitas, but to also work as a strategic partner to assist Avitas with their penetration of the infused water market. Moving forward, our corporate vision is to continue to provide the Powered by Xanthic technology to producers and distributors across various product categories and in multiple jurisdictions,” noted Moore.
Xanthic Biopharma is changing the cannabis paradigm and enabling its strategic partners to produce high quality, innovative, non-combustible cannabis and cannabis-infused products which deliver consistent THC and/or CBD levels with superior cannabinoid solubility and consistency.
Not currently public, Xanthic is taking all of the necessary steps to apply for listing on the Canadian Securities Exchange. Once listed, the stock could be ‘Powered by Xanthic’ and, given the social and economic advantages of Xanthic’s breakthrough technology, it could be quite a ride.
For more information, visit the company’s website at www.XanthicBio.com
More from CannabisNewsWire
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
